Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity

Table 5 Relationship between MVC and presence of p53 and VEGF (mean ± SD, n (%))

	Patients,	MVC	Total
	VEGF(+)	VEGF(-)
p53(+)	27 (55.1%)	3 (6.1%)	30 (61.2%)
	41 ±  9	35 ± 10	36 ± 10
p53(-)	4 (8.2%)	15 (30.6%)	19 (38.8%)
	36 ± 12	28 ± 13a	30 ± 12e
Total	31 (63.3%)	18 (36.7%)	49 (100%)
	37 ± 11	30 ± 12c

^aP<0.05 vs others,

^cP<0.05 vs “VEGF(+)” group,

^eP<0.05 vs“p53(+)” group.